by FBorchert | Jan 17, 2025 | News
The scientific and commercial members of the globally unique radiopharmaceutical competence cluster Dresden/Radeberg (Saxony, Germany), comprehensively covering the entire radiopharmaceutical value creation chain from targetry, discovery over R & D, manufacturing,...
by FBorchert | Jan 13, 2025 | News
In 2025 we would like to take the opportunity to welcome our new employee in India: Dr. Rakhee Vatsa! She has started at ABX-CRO India in September 2024 as Technical Head CDMO. Since then she has been awarded the Distinguished Alumnus Award on Dec 21, 2024 by the...
by FBorchert | Oct 2, 2024 | News
We are extremely proud that our central involvement in designing, execution and analysis of of the Telix ZIRCON pivotal phase III study was recently recognised in The Lancet Group Oncology. This prospective, open-label, multicentre study evaluated the clinical utility...
by FBorchert | Jun 21, 2024 | News
This summer we welcome our first two trainees. We look forward to seeing them learn and...
by FBorchert | May 16, 2024 | News
We are proud to announce that the dosimetry software QDOSE® designed by us and our development partner Quantinm AB will now become part of a commercial partnership with Telix. Telix intends to integrate the platform into its therapeutic radiopharmaceutical programmes...
by FBorchert | May 10, 2024 | News
Summer 2024 is coming up and as every year we are returning to the SNMMI 2024 in Toronto, Canada on June 8-11. Our two General Managers, Dr. Andreas Kluge and Andreas Fintelmann, and the CEO of ABX-CRO INC, Moritz Kallerhoff, will be there again accompanied by our...
